Jefferies analyst David Windley assumed coverage of Cerner (CERN) with a Hold rating, down from the firm's prior Buy rating, stating that he thinks spending for hospital IT is challenged after years of aggressive implementations. He believes the market understands Cerner's path well and believes the company's margin targets "require some heavy lifting," Windley stated. He also assumed coverage of NextGen Healthcare (NXGN) with an unchanged Hold rating and assumed coverage of Allscripts (MDRX) and Vocera (VCRA) with unchanged Buy ratings. Windley set a $75 price target on Cerner shares, up from the firm's prior $69 target.